ConditionCancer
Tonsil Cancer
Tonsil cancer is a cancer that starts in the tonsils at the back of the throat and is the most common type of oropharyngeal cancer. Most cases today are caused by human papillomavirus (HPV), especially HPV 16, and occur in adults aged 40 to 60, many of whom have never smoked. The first sign is often a painless lump in the neck, one tonsil that is larger than the other, a sore throat that will not go away, or ear pain on one side. HPV-positive tonsil cancer responds well to treatment.
Also called: Tonsillar cancer, oropharyngeal cancer of the tonsil, tonsillar squamous cell carcinoma, HPV-positive oropharyngeal cancer
At a glance
- What it is
- A cancer (usually squamous cell carcinoma) of the tonsils in the oropharynx.
- Causes
- HPV (most cases in the US), smoking and heavy alcohol use.
- Early signs
- Painless neck lump, one enlarged tonsil, persistent sore throat, one-sided ear pain, swallowing difficulty.
- Diagnosis
- Examination, biopsy, HPV (p16) testing, CT, MRI or PET-CT.
- Treatment
- Transoral surgery, radiotherapy, often with chemotherapy. Immunotherapy for advanced disease.
When to get help
Call 911 or go to the ER
- Difficulty breathing or noisy breathing
- Coughing or vomiting significant blood
See a doctor within a day or two
- Being unable to swallow liquids, or rapid weight loss
- A neck lump that is growing quickly
Book a routine appointment
- A lump in the neck lasting more than 2 to 3 weeks
- One tonsil noticeably larger than the other, especially in an adult
- A sore throat, ear pain on one side or difficulty swallowing lasting more than 3 weeks
- A sore or ulcer on a tonsil that does not heal
- Hoarseness lasting more than 3 weeks
Usually safe to manage at home
- A sore throat with a cold or fever that improves within 1 to 2 weeks
HPV-positive vs HPV-negative tonsil cancer
Tonsil cancer is a form of oropharyngeal cancer, part of the wider group of head and neck cancers.
| Feature | HPV-positive | HPV-negative |
|---|---|---|
| Main cause | HPV 16 infection | Smoking and alcohol |
| Typical patient | 40 to 60, often non-smokers, more often men | Older, heavy smoking and drinking history |
| First sign | Often a painless, sometimes cystic neck lump | Sore throat, ulcer, pain |
| Response to treatment | Very good | Less favorable |
| 5-year survival | High, often over 80% to 90% for many stages | Lower |
HPV-related oropharyngeal cancer has risen sharply in recent decades in the US and is now more common than HPV-related cervical cancer.
Risk factors
- HPV infection, mainly through oral sex and number of oral sex partners
- smoking and other tobacco use
- heavy alcohol use, especially combined with smoking
- weakened immunity, including HIV
- male sex
Symptoms
- a painless lump in the neck (enlarged lymph node), often the first sign
- one tonsil larger than the other (unlike tonsillitis, which usually affects both and settles within days)
- persistent sore throat
- pain in one ear (referred pain)
- difficulty or pain when swallowing
- a sore or white or red patch on the tonsil
- bleeding from the mouth
- changes in voice
- weight loss
Diagnosis
- examination of the mouth, throat and neck
- flexible nasendoscopy: a thin camera through the nose
- biopsy of the tonsil, or a fine-needle aspiration of a neck lump
- HPV testing: p16 staining and sometimes HPV DNA or RNA tests, which affect staging and outlook
- imaging: CT or MRI of the neck, PET-CT to check spread
- dental assessment before radiotherapy
HPV-positive and HPV-negative cancers are staged separately because their outcomes differ.
Treatment
Treatment is planned by a head and neck cancer team.
Early-stage disease
- transoral robotic surgery (TORS) or transoral laser surgery to remove the tonsil and tumor, often with removal of neck lymph nodes
- or radiotherapy alone
More advanced disease
- chemoradiotherapy: radiotherapy combined with cisplatin chemotherapy
- surgery followed by radiotherapy with or without chemotherapy, depending on findings
Recurrent or metastatic disease
- immunotherapy (pembrolizumab or nivolumab), chemotherapy, cetuximab
- clinical trials, including treatment de-escalation for HPV-positive cancers
Side effects
- dry mouth and taste changes
- difficulty swallowing
- sore mouth (mucositis)
- neck stiffness and lymphedema
- dental problems and jaw bone damage
- hearing loss and kidney effects from cisplatin
Speech and swallowing therapy, dietitians and dental care help recovery.
Outlook
HPV-positive tonsil cancer has an excellent outlook, with high cure rates even when lymph nodes are involved. HPV-negative cancers, often linked with smoking, have lower survival. Stopping smoking improves treatment outcomes.
Prevention
- HPV vaccination, recommended at age 11 to 12 with catch-up through 26, protects against the HPV types that cause most oropharyngeal cancers
- not smoking and limiting alcohol
- regular dental checks, which can pick up mouth and throat changes
- seeing a doctor for persistent throat symptoms or neck lumps
Frequently asked questions
What are the first signs of tonsil cancer?
The first sign is often a painless lump in the neck. Others include one tonsil larger than the other, a sore throat or one-sided ear pain lasting more than 3 weeks, and difficulty swallowing.
Is tonsil cancer caused by HPV?
Most tonsil cancers in the US are caused by HPV, especially HPV type 16. Smoking and heavy drinking cause most of the rest. HPV-related cancers tend to respond better to treatment.
What is the survival rate for tonsil cancer?
HPV-positive tonsil cancer has a high survival rate, often over 80% to 90% at 5 years for many stages. HPV-negative cancers have lower survival. Your care team can give a personalized estimate.
How is tonsil cancer treated?
Treatment may include surgery through the mouth, radiotherapy, chemotherapy or a combination. Advanced or recurrent cancer may be treated with immunotherapy. A head and neck cancer team plans treatment.
Can the HPV vaccine prevent tonsil cancer?
The HPV vaccine protects against HPV types that cause most oropharyngeal cancers, including tonsil cancer. Vaccination at age 11 to 12, before exposure, is most effective.
Sources
This guide was written from current patient and clinical guidance, including:
- American Cancer Society: Oral cavity and oropharyngeal cancer
- National Cancer Institute: Oropharyngeal cancer treatment (PDQ); HPV and cancer
- National Comprehensive Cancer Network (NCCN): Head and neck cancers guidelines
- CDC: HPV-associated oropharyngeal cancer
- American Academy of Otolaryngology-Head and Neck Surgery: Throat cancer